These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22731255)

  • 21. Sex-specific clinical outcomes of impaired glucose status: A long follow-up from the Tehran Lipid and Glucose Study.
    Parizadeh D; Rahimian N; Akbarpour S; Azizi F; Hadaegh F
    Eur J Prev Cardiol; 2019 Jul; 26(10):1080-1091. PubMed ID: 30862232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of future fasting and 2-h post-OGTT plasma glucose levels in middle-aged men and women-the Inter99 study.
    Faerch K; Vaag A; Witte DR; Jørgensen T; Pedersen O; Borch-Johnsen K
    Diabet Med; 2009 Apr; 26(4):377-83. PubMed ID: 19388967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematocrit and the risk of cardiovascular disease in a Japanese community: The Hisayama Study.
    Gotoh S; Hata J; Ninomiya T; Hirakawa Y; Nagata M; Mukai N; Fukuhara M; Ikeda F; Ago T; Kitazono T; Kiyohara Y
    Atherosclerosis; 2015 Sep; 242(1):199-204. PubMed ID: 26204496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of fasting plasma glucose to predict mortality or coronary heart disease in persons > or = 60 years of age without diabetes mellitus or in those with undiagnosed diabetes mellitus (from The Dubbo Study).
    Simons LA; Simons J; Friedlander Y; McCallum J
    Am J Cardiol; 2008 Oct; 102(7):831-4. PubMed ID: 18805106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of fasting and/or postprandial glucose on heart rate recovery in patients with coronary heart disease.
    Gayda M; Bourassa MG; Tardif JC; Fortier A; Juneau M; Nigam A
    Diabetes Metab; 2012 Feb; 38(1):20-6. PubMed ID: 21868273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The difference between acute coronary heart disease and ischaemic stroke risk with regard to gender and age in Finnish and Swedish populations.
    Hyvärinen M; Qiao Q; Tuomilehto J; Söderberg S; Eliasson M; Stehouwer CD
    Int J Stroke; 2010 Jun; 5(3):152-6. PubMed ID: 20536610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired glucose regulation in adults in Jamaica: who should have the oral glucose tolerance test?
    Sargeant LA; Boyne MS; Bennett FI; Forrester TE; Cooper RS; Wilks RJ
    Rev Panam Salud Publica; 2004 Jul; 16(1):35-42. PubMed ID: 15333264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Body surface area may explain sex differences in findings from the oral glucose tolerance test among subjects with normal glucose tolerance.
    Palmu S; Kuneinen S; Kautiainen H; Eriksson JG; Korhonen PE
    Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2678-2684. PubMed ID: 34218989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study.
    Sicree RA; Zimmet PZ; Dunstan DW; Cameron AJ; Welborn TA; Shaw JE
    Diabet Med; 2008 Mar; 25(3):296-302. PubMed ID: 18307457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long term prognostic implication of newly detected abnormal glucose tolerance among patients with stable cardiovascular disease: a population-based cohort study.
    Kabootari M; Asgari S; Ghavam SM; Abdi H; Azizi F; Hadaegh F
    J Transl Med; 2021 Jun; 19(1):277. PubMed ID: 34193200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triglyceride to high-density lipoprotein cholesterol ratio and risk of atherosclerotic cardiovascular disease in a Chinese population.
    Zhou L; Mai J; Li Y; Guo M; Wu Y; Gao X; Wu Y; Liu X; Zhao L
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1706-1713. PubMed ID: 32811737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose.
    Qiao Q; Pyörälä K; Pyörälä M; Nissinen A; Lindström J; Tilvis R; Tuomilehto J
    Eur Heart J; 2002 Aug; 23(16):1267-75. PubMed ID: 12175663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases.
    Park C; Guallar E; Linton JA; Lee DC; Jang Y; Son DK; Han EJ; Baek SJ; Yun YD; Jee SH; Samet JM
    Diabetes Care; 2013 Jul; 36(7):1988-93. PubMed ID: 23404299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid profile components and incident cerebrovascular events versus coronary heart disease; the result of 9 years follow-up in Tehran Lipid and Glucose Study.
    Tohidi M; Mohebi R; Cheraghi L; Hajsheikholeslami F; Aref S; Nouri S; Azizi F; Hadaegh F
    Clin Biochem; 2013 Jun; 46(9):716-21. PubMed ID: 23531403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visit-to-Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All-Cause Mortality in the General Population.
    Wang A; Liu X; Xu J; Han X; Su Z; Chen S; Zhang N; Wu S; Wang Y; Wang Y
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin Resistance Index from Oral Glucose Tolerance Test Predicts Ischemic Stroke Outcomes in Non-Diabetic Patients with Different Estimated Glomerular Filtration Rate Strata.
    Zhou Y; Zhang Y; Pan Y; Jing J; Zhao X; Liu L; Wang C; Li H; Yan H; Meng X; Wang Y; Wang Y;
    Cerebrovasc Dis; 2018; 46(3-4):142-151. PubMed ID: 30235440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland.
    Pyöräla K
    Diabetes Care; 1979; 2(2):131-41. PubMed ID: 520116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Independent associations of fasting insulin, glucose, and glycated haemoglobin with stroke and coronary heart disease in older women.
    Lawlor DA; Fraser A; Ebrahim S; Smith GD
    PLoS Med; 2007 Aug; 4(8):e263. PubMed ID: 17760500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fasting plasma glucose in non-diabetic elderly women predicts increased all-causes mortality and coronary heart disease risk.
    Simons LA; Friedlander Y; McCallum J; Simons J
    Aust N Z J Med; 2000 Feb; 30(1):41-7. PubMed ID: 10800877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.